The Pharmaceutical Strategy Series (PSS) mission is to assist in improving the overall health of the pharmaceutical industry by producing high level meetings that bring together R&D leaders, representing the largest therapeutic companies in the world, to discuss and debate potential solutions to overcoming the most pressing challenges facing their organizations.  PSS programs have been designed to help R&D leaders and corporate executives assess business opportunities, evaluate R&D strategy, enhance corporate value and better forecast the economic and regulatory landscape within the rapidly changing pharmaceutical & biotechnology industries. Presentations in each Executive Forum, Summit or Congress provide the ideas and information managers need to make faster and smarter decisions. PSS determines its programming and speakers based largely on advice and contacts provided by the PSS Advisory Board. The PSS Advisory Board, listed below, is comprised of decision-makers and thought leaders at most of the world's leading biopharmaceutical companies. The Pharmaceutical Strategy Series (PSS) is a division of Cambridge Healthtech Institute (CHI).